原创 Cell子刊：哈佛大学发布iPSC干细胞治疗帕金森病临床前数据
帕金森病（Parkinson’s Disease，PD），是一种复杂的神经退行性疾病，也是世界上第二常见的神经退行性疾病，仅次于阿尔茨海默病（AD），影响着约 1?% 的 65 岁及以上老人。随着全球人口老龄化，帕金森病患病率还将大幅增加。 人诱导多能干细胞（hiPSC）来源的中脑多巴胺能细胞（mDAC）为帕金森病的自体细胞疗法提供了一个有前景的来源，但标准化的调控标准对于临床转化至关重要。 20 ...
gut.bmj2 天
Reparative immunological consequences of stem cell transplantation as a cellular therapy ...
Background Treatment strategies for Crohn’s disease (CD) suppress diverse inflammatory pathways but many patients remain ...
生物谷3 天
Cell子刊：哈佛大学发布iPSC干细胞治疗帕金森病临床前数据
在这项临床前研究中，研究团队利用体重编程技术从四名散发的帕金森病患者新活检的成纤维细胞中生成了多个临床级人诱导多能干细胞（hiPSC），并采用优化的 21 天方案将其分化为中脑多巴胺能细胞（mDAC）。
Pharmabiz4 天
US FDA grants fast track designation to NKGen Biotech’s natural killer cell therapy ...
US FDA grants fast track designation to NKGen Biotech’s natural killer cell therapy, troculeucel to treat moderate Alzheimer’s disease: Santa Ana, California Saturday, Februar ...
Cell Therapy Market To Skyrocket From $4.65 Billion In 2023 To $28.98 Billion By 2032 At A ...
Cell Therapy Market Technological breakthroughs, increased funding, and personalized medicine fuel the exponential growth of the global cel ...
Bahrain Makes History with First Successful CRISPR-Based Sickle Cell Treatment Outside the US
This achievement follows Bahrain’s landmark decision on 2 December 2023 to become the second country globally and the first ...
Targeted Oncology11 天
Exploring Maintenance Strategies Post Autologous Transplant
Panelists discuss how to optimize maintenance therapy following autologous stem cell transplantation by evaluating factors such as duration, drug selection, and risk-adapted approaches to maximize ...